EUDA Health Holdings Limited - SIC # 8081 -

Ticker Exchange SIC # Website Latest Ticker
EUDA Nasdaq 8081 eudahealth.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for EUDA Health Holdings Limited

EUDA Highlights Shenzhen Inno’s Approval Under Shenzhen Key Industry R&D Program for TCR-T Cell Therapy Development - Apr 28th, 2026 4:00 am
EUDA Health Holdings Limited Has Received Notice from Nasdaq that it has Failed to Maintain a Minimum Market Value of its Listed Securities - Apr 27th, 2026 4:00 am
EUDA Announces Reverse Stock Split of its Ordinary Shares - Mar 19th, 2026 3:30 am
EUDA Health price target lowered to $2.75 from $6 at Greenridge - Mar 10th, 2026 8:00 am
EUDA Health Holdings Limited Announces Repurchase and Cancellation of Streeterville Warrant - Mar 4th, 2026 7:10 am
EUDA Health Announces Second Amendment to Streeterville Warrant Agreement - Jan 15th, 2026 6:59 am
EUDA Enters into Convertible Loan Agreement with Shenzhen Inno, Further Expanding Stem Cell Therapy Platform - Jan 13th, 2026 5:49 am
EUDA Health Holdings Limited Announces Amendment to Streeterville Warrant Agreement - Jan 7th, 2026 4:00 am
EUDA Launches Nationwide Stem Cell Extraction, Cryostorage and Clinical Delivery Platform in China with Shenzhen Inno Immune and Wuhan Kaien Hospital - Dec 30th, 2025 5:00 am
EUDA Health to Launch EUDA Helixé 2.0 in January 2026 - Dec 29th, 2025 5:00 am
Top Midday Gainers - Dec 23rd, 2025 11:44 am
EUDA Accelerates Longevity Strategy with Launch of Comprehensive Stem Cell Therapy Platform and First Clinic in Shenzhen - Dec 23rd, 2025 5:00 am
Top Midday Decliners - Dec 22nd, 2025 11:36 am
EUDA Health Holdings Limited Announces Execution of Securities Purchase Agreement - Dec 5th, 2025 7:30 am
EUDA Subsidiary CK Health Plus Expands into India in Strategic Partnership with SafeRock India - Oct 23rd, 2025 7:00 am
EUDA Subsidiary CK Health Plus Secures Malaysia Direct Selling License, Strengthening Its Longevity Business Across Asia - Oct 20th, 2025 7:00 am
EUDA Signs Letter of Intent to Potentially Acquire GO POSB - Sep 10th, 2025 7:30 am
EUDA Strategically Expands into T-Cell Immunotherapy – Strengthening Its Stem Cell Therapy Portfolio - Sep 4th, 2025 6:00 am
EUDA Signs Letter of Intent to Potentially Acquire Chemokine Pte Ltd - Aug 28th, 2025 6:00 am
EUDA Expands Wellness Product Portfolio With A Next-Generation Immune Health Supplement - Aug 26th, 2025 6:00 am